COVID protocol 37: Inhaled steroids for covid respiratory symptoms

Written By: user

IJCP Editorial Team

Published On: 26 Apr, 2021 2:11 PM | Updated On: 15 May, 2024 4:51 PM

COVID protocol 37: Inhaled steroids for covid respiratory symptoms

After the discussions that took place in the Confederation of Medical Association in Asia & Oceania (CMAAO) followed by the round table at Heart Care Foundation of India (HCFI-RT), the following Sutra (Sutra 4) was passed. This now becomes a part of Dr. K. K. Aggarwal's Covid protocol no. 36, i.e. control the inflammation by Day 3 and thrombo-inflammation by Day 5 of Covid-19.

Covid inflammation is at its peak on Day 3 - pneumonia occurs, time for CT scan, CRP is at its peak, and TH1 response inflammation occurs.

By Day 5, if inflammation is not targeted, one may develop TH17 response, neutrophil recruitment, and thrombo-inflammation.

Bring CRP to <5 by Day 5. If this target is missed, try to bring CRP to <10 by Day 10. If even this target is not attainable, then the prognosis is poor.

Article Tags

asthma covid-19 respiratory-infection

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.